Take the Next STEP in Your Spasticity EducationAAPM&R is arming members with training to help them prepare and lead in competitive landscapes. Following the success of the highly-acclaimed STEP Ultrasound Certificate Program, we are excited to announce the launch of the STEP Interventional Spasticity Certificate Program.
STEP stands for Skills, Training, Evaluation and Performance. The STEP Interventional Spasticity Certificate Program teaches and assesses interventional spasticity skills using a standardized, progressive, and competency-based curriculum with both online and live components.
When you earn the STEP Interventional Spasticity Program Certificate, you:
Learning ObjectivesAfter completion of the STEP Interventional Spasticity Program, participants should be able to:
Participants move through a series of 3 STEPs. Those who complete all the required STEPs earn a Certificate of Completion.
CME and MOC CreditThis STEP program offers 31.25 AMA PRA Category 1 Credits™:
PrerequisitesRecommended prerequisites for successful completion of the program are:
AccreditationThe American Academy of Physical Medicine and Rehabilitation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of CreditSTEP 1 - Online Program The American Academy of Physical Medicine and Rehabilitation (AAPM&R) designates this enduring material for a maximum of 16 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
STEP 2 - Live Course The American Academy of Physical Medicine and Rehabilitation (AAPM&R) designates this live activity for a maximum of 15.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The live course has also been approved by the American Board of Physical Medicine and Rehabilitation (ABPMR) for a maximum of 15.25 Maintenance of Certification® (MOC®) Part II Self-Assessment credits. Attendees must actively participate and complete a self-evaluation at the conclusion of the course to earn MOC Part II credit.
STEP 3 - Assessment and CertificateCompletion of the entire program, which includes passing the assessment and submitting your case log, will count towards your American Board of Physcial Medicine and Rehabilitation MOC Part IV requirements.
Financial DisclosuresAAPM&R requires all individuals who are in a position to affect the strategic direction of AAPM&R and/or the content of an educational activity to disclose any financial relationships with an ineligible company within the last 24 months. The ACCME defines an Ineligible Company as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients”. The ACCME does not consider providers of clinical service directly to patients to be an ineligible company. Disclosures are made in written form prior to the start of the educational activity and any potential conflicts of interest that exist are resolved prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to control content and their disclosed financial relationships are listed below.
STEP Spasticity Workgroup Roy L. Adair, MD: Disclosed no relevant financial relationships Abraham Alfaro, PhD, DO: Disclosed no relevant financial relationships Katharine E. Alter, MD: Disclosed no relevant financial relationships Keith D Baldwin, MD, MSPT, MPH: Pfizer: Stock OptionsGerald S. Bilsky, MD: Medtronic and Saol Pharmaceuticals: Speakers' BureauKristin E. Caldera, DO: Medtronic: Speakers' BureauJeimylo C. de Castro, MD: Disclosed no relevant financial relationships Jennifer E. Doble, MD: Disclosed no relevant financial relationships Franklin SP Domingo, MD: Disclosed no relevant financial relationships Steve V. Escaldi, DO: Saol Pharmaceuticals: Consultant Alberto Esquenazi, MD: Disclosed no relevant financial relationships Reza Farid, MD: Disclosed no relevant financial relationships Nicholas A. Godby, MD: Disclosed no relevant financial relationships Fatma Gul, MD: Disclosed no relevant financial relationships Shivani Gupta, DO: Disclosed no relevant financial relationships Ryan C. Hafner, MD: Disclosed no relevant financial relationships Patricia J. Hantsch, MD: Disclosed no relevant financial relationships Kimberly Heckert, MD: Merz Therapeutics, Piramal, and Saol Pharmaceuticals: Spasticity fellowship program received educational grantsDidem Inanoglu, MD: Ipsen: Trainer/Faculty and Consultant; Allergan: Consultant, Advisory BoardCindy B. Ivanhoe, MD: Disclosed no relevant financial relationships Mary Ann Keenan, MD: Disclosed no relevant financial relationships Nicholas C. Ketchum, MD: Medtronic: Speakers' Bureau and Consulting; Saol Pharmaceuticals: ConsultingHeakyung Kim, MD: Disclosed no relevant financial relationships Linda E. Krach, MD: Disclosed no relevant financial relationships Christina Kwasnica, MD: Ipsen Pharmaceuticals Speakers’ BureauJohn Lin, MD: Disclosed no relevant financial relationships Sheng Li, MD PhD: Disclosed no relevant financial relationships Amy A. Mathews, MD: Disclosed no relevant financial relationships John R. McGuire, MD: Disclosed no relevant financial relationships Daniel K. Moon, MD: Disclosed no relevant financial relationships Marisa Moreta, DO: Disclosed no relevant financial relationships Michael C. Munin, MD: Disclosed no relevant financial relationships Patricia Nance, MD: Disclosed no relevant financial relationships Marilyn S. Pacheco, MD: Disclosed no relevant financial relationships Atul T. Patel, MD, MHSA: Allergan and Ipsen Research: Grants and Speakers' BureauNatasha L. Romanoski, DO: Disclosed no relevant financial relationships Michael F. Saulino, MD PhD: Disclosed no relevant financial relationships Mary E. Russel, DO, MS: Merz Therapeutics and Allergan Speakers' BureauErik T. Shaw, DO: TerSera Therapeutics, Boston Scientific, and SPR Therapeutics: Consultant; BDSI: Speakers' BureauAndrea P. Toomer, MD: Flowonix and Ipsen Biopharmaceuticals: Research/Speakers Bureau; Medtronic and Piramal: Speakers BureauJose A. Urquidez, MD: Disclosed no relevant financial relationships Monica Verduzco-Gutierrez, MD: AbbVie and Merz Therapeutics: Consultant/Speakers' Bureau; Ipsen Biopharmaceuticals: Consultant/Research Grant/Speakers' BureauHeather W. Walker, MD: Disclosed no relevant financial relationships Thomas K. Watanabe, MD : Disclosed no relevant financial relationships Medical Education CommitteeJohn C. Cianca, MD: Musculoskeletal Ultrasound Consultants, LLC: OwnershipKaren P. Barr, MD: Disclosed no relevant financial relationships Rachel A. Brakke Holman, MD: Disclosed no relevant financial relationships Joseph E. Burris, MD: Allergan: Speakers Bureau and Research Grant David S. Cheng, MD: Disclosed no relevant financial relationships Theresa A. Gillis, MD: Disclosed no relevant financial relationships Kevin N. Hakimi, MD: Disclosed no relevant financial relationships Matthew T. Haas, MD: Disclosed no relevant financial relationships Sam Mayer, MD: Demos Medical Publishing: RoyaltiesAmeet S. Nagpal, MD MS MEd: Disclosed no relevant financial relationships Sunil Sabharwal, MD: Demos Publishing: Royalities; American Board of Physical Medicine and Rehabilitation: Board MemberSarah M. Smith, MD: Disclosed no relevant financial relationships Stephanie Tow, MD: Disclosed no relevant financial relationships Kevin R. Vincent, MD: Disclosed no relevant financial relationships
Continuing Medical Edcuation Committee Karen P. Barr, MD: Disclosed no relevant financial relationships Cherry C. Junn, MD: Disclosed no relevant financial relationships Sheryl R. Levin, MD: Disclosed no relevant financial relationships Kentaro Onishi, DO: Disclosed no relevant financial relationships Evan R. Peck, MD: Disclosed no relevant financial relationships Cynthia G. Pineda, MD: Disclosed no relevant financial relationships Patricia T. Tan, MD: Disclosed no relevant financial relationships Brionn K. Tonkin, MD: Disclosed no relevant financial relationships Kristin A. Wong, MD: Disclosed no relevant financial relationships No other planners, faculty or individuals in control of content disclosed any financial relationships. Through the planning process, all relevant financial relationships have been mitigated. Support Partial support for AAPM&R’s Interventional Spasticity Management Applications has been provided through educational grants from AbbVie, Ipsen Biopharmaceuticals and Merz Therapeutics in accordance with ACCME Guidelines for Integrity and Independence.